Genus Lifesciences Inc. v. Lannett Company, Inc.

CourtDistrict Court, N.D. California
DecidedDecember 30, 2019
Docket3:18-cv-07603
StatusUnknown

This text of Genus Lifesciences Inc. v. Lannett Company, Inc. (Genus Lifesciences Inc. v. Lannett Company, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Genus Lifesciences Inc. v. Lannett Company, Inc., (N.D. Cal. 2019).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 GENUS LIFESCIENCES INC., Case No. 18-cv-07603-WHO

8 Plaintiff, ORDER GRANTING MOTION TO QUASH SUBPOENA; DENYING AS 9 v. MOOT MOTION TELEPHONIC APPEARANCE AND FOR 10 LANNETT COMPANY, INC., et al., PERMISSION FOR ELECTRONIC CASE FILING Defendants. 11 Re: Dkt. Nos. 87, 89, 90

13 INTRODUCTION 14 Non-party Michael Singer moves to quash a subpoena issued by plaintiff Genus 15 Lifesciences Inc. (“Genus”) to produce documents relating to Singer’s former employment with 16 defendant Lannett Company Inc. (“Lannett”). Singer requests that the subpoena be quashed 17 because it would result in a significant expense, could subject him to sanctions from Lannett for 18 producing privileged or confidential information, and is unduly burdensome because the requested 19 documents are also in Lannett’s possession. Genus has not requested the documents from Lannett. 20 I agree with Singer, particularly regarding the burden Genus seeks to impose on him before 21 seeking the same documents from a party to the litigation, and GRANT his motion to quash. His 22 subsequent motions for telephonic appearance and permission for electronic case filing are 23 DENIED as moot. 24 BACKGROUND 25 I. PROCEDURAL BACKGROUND 26 Genus sued defendants, competitors in the market of cocaine hydrochloride nasal spray, for 27 falsely advertising, marketing and promoting their product and unfairly competing with it in ways 1 that violate the law. See First Amended Complaint [Dkt. No. 54]. On September 12, 2019, Genus 2 served a document subpoena on non-party Michael Singer, a former salesperson for defendant 3 Lannett who specialized in marketing and selling Lannett’s products. See Declaration of Jason N. 4 Haycock in Support of Plaintiff Genus Lifesciences Inc.’s Response to Michael Singer’s Motion 5 to Quash Subpoena or for Protective Order (“Haycock Decl.”) [Dkt. No. 93] ¶ 3 & Ex. 1 (copy of 6 document subpoena served on Michael Singer). 7 After back and forth between the parties, as detailed below, Singer filed this motion to 8 quash subpoena and/or for a protective order. See Notice of Motion and Motion to Quash 9 Subpoena and for Protective Order and Memorandum of Points and Authorities in Support of 10 Motion for Protective Order (“Mot.”) [Dkt. No. 87]. Although his motion was not noticed for a 11 hearing date, Singer requests telephonic appearance. Dkt. No. 89. Because Singer is proceeding 12 pro se, he also seeks permission for electronic case filing. See Dkt. No. 90. 13 Genus responded to Singer’s motion on October 29, 2019. See Plaintiff Genus 14 Lifesciences, Inc.’s Brief in Response to Michael Singer’s Motion to Quash or for Protective 15 Order (“Oppo.”) [Dkt. No. 92]. Lannett has not filed a response to this motion. 16 II. FACTUAL BACKGROUND 17 Genus’s document subpoena requests three categories of documents: (i) agreements Singer 18 has, or had in the past, with Lannett, including employment agreement(s); (ii) promotional 19 literature, advertisements, and training materials related to cocaine hydrochloride; and (iii) 20 communications with Lannett, doctors, pharmacists, surgery centers, or other customers related to 21 cocaine hydrochloride. Haycock Decl., Ex. 1. 22 On September 24, 2019, Singer acknowledged receipt of the subpoena and proposed a plan 23 to respond. See Haycock Decl., Ex. 2 (copy of letter from Singer to Genus); Affidavit of Michael 24 Singer Regarding Motion for Protective Order [Dkt. No. 88], Ex. 1 (same). Singer proposed that 25 he would review his files, make a list of documents in his possession, and then submit the list to 26 Genus and Lannett. Id. He requested that Genus and Lannett review the list to determine which 27 documents should be produced under the Protective Order. Id. He requested $0.45 per copy and 1 On September 28, 2019, Genus responded, providing Singer with more time to comply 2 with the document subpoena, agreeing to compensate him up to $500 in photocopying costs and 3 $1,000 for his time, and offering to designate all produced documents as “Highly Confidential” 4 under the Protective Order so as to avoid any issue about confidentiality. See Haycock Decl., Ex. 5 3. 6 On September 30, 2019, Singer told Genus he was afraid that Lannett would sue him if he 7 produced the documents in his possession, and reiterated his initial proposal to provide a list of 8 documents to Genus and Lannett so that they could determine what should be produced. Id., Ex. 9 4. Singer also expressed concerns about Genus’s reimbursement caps, stating that “If you cap it, 10 then I will work to the time of the caps and then stop.” Id. 11 On October 2, 2019, Lannett informed Genus and Singer that the documents in Singer’s 12 possession “may implicate Lannett’s attorney-client (or other) privilege.” Haycock Decl., ¶ 7 & 13 Ex. 5. Lannett demanded that it review the documents prior to production “to ensure that 14 privileged documents are not produced.” Id. Lannett suggested that Genus instruct Singer “to 15 provide all potentially responsive documents to Lannett’s counsel,” and then Lannett would 16 “review those documents and produce any responsive, non-privileged documents to Genus within 17 10 business days.” Id. 18 On October 3, 2019, Singer responded to both parties, reiterating his proposal to send a list 19 of documents to the parties for review and again demanding full compensation for his time. 20 Haycock Decl., ¶ 8 & Ex. 6. He stated that if the parties could not agree to his proposal, then he 21 would file a motion for protective order “to protect himself.” Id. 22 On October 9, 2019, Genus agreed to Singer’s compensation terms and proposed the 23 following three-step process for resolution: “(1) Mr. Singer would review his files for hard-copy 24 and digital records (up to 4 hours); (2) he would prepare a list of documents and send the list to 25 Genus and Lannett (up to 1.5 hours); and (3) then submit the documents electronically to counsel 26 for Lannett. Lannett’s counsel would review the materials and produce all non-privileged 27 documents within ten days.” Oppo. 4-5; Haycock Decl. ¶ 9 & Ex. 7. Genus states that it set the 1 letter. Oppo. 5; see Haycock Decl., Ex. 2 (stating that Singer believes it will take him 4 hours to 2 review all documents and 1.5 hours to list the responsive documents). With this proposed 3 resolution, Genus agreed to reimburse Singer up to $500 for photocopying costs and increased its 4 offer to compensate Singer at his request for $250 per hour for estimated 5.5 hours to locate and 5 send a list of documents to Genus and Lannett. Oppo. 5; see Haycock Decl., Ex. 7. 6 On October 10, 2019, Singer acknowledged and agreed that at least “we are all now on the 7 same page as to how to handle the documents and to keep myself protected as we all finally 8 agree.” Haycock Decl., ¶ 11 & Ex. 8. But he contended that he already spent 5 hours in dealing 9 with this back and forth and under Genus’s solution would only spend another half hour going 10 through his documents and compiling a list. Id. 11 Later the same day, Lannett objected to Genus’s solution on two grounds. Haycock Decl., 12 ¶ 12 & Ex. 9. First, it argued that Singer should not provide Genus with even the list of 13 documents because “the list may itself” disclose privileged or highly confidential information. Id. 14 Second, despite its earlier agreement to produce non-privileged documents to Genus ten days after 15 receipt from Singer, Lannett asserted that it does not know the nature and volume of the 16 documents and therefore will provide non-privileged responsive documents to Genus “as quickly 17 as practicable.” Id. 18 The next day, on October 11, 2019, Singer responded that “there is no agreement [on] how 19 to handle the documents” and stated that he is “unwilling to play this back and forth game with the 20 parties.” Haycock Decl., ¶ 13 & Ex. 10.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Soto v. Castlerock Farming & Transport, Inc.
282 F.R.D. 492 (E.D. California, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Genus Lifesciences Inc. v. Lannett Company, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/genus-lifesciences-inc-v-lannett-company-inc-cand-2019.